Market Forecast By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion), By Route of Administration (Subcutaneous, Intramuscular, Intranasal) And Competitive Landscape
Product Code: ETC312423 | Publication Date: Aug 2022 | Updated Date: May 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Mexico Animal Vaccines market currently, in 2023, has witnessed an HHI of 8176, Which has increased moderately as compared to the HHI of 7762 in 2017. The market is moving towards Highly concentrated. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
Report Name | Mexico Animal Vaccines Market |
Forecast period | 2024-2030 |
CAGR | 6.4% |
Growing Sector | Poultry |
Mexico Animal Vaccines Market report thoroughly covers the market product, by animal type and by route of administration. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Mexico Animal Vaccines Market has accomplished significant growth and is projected to attain more growth in the coming years due to increasing awareness about animal health and preventive measures against diseases. Factors such as the expanding livestock population, rising pet adoption rates, and government initiatives towards animal vaccination programs have played pivotal roles in shaping the market dynamics.
According to 6Wresearch, Mexico Animal Vaccines Market size is likely to grow at a CAGR of 6.4% during the forecast period 2024-2030. Several factors are driving the Mexico Animal Vaccines Market Growth such as the increasing awareness and concern for animal health among pet owners and livestock farmers catalyses the demand for vaccines as a pivotal element of preventive healthcare. The rise in pet adoption rates further amplifies the necessity for regular vaccination, aiming to prevent the spread of infectious diseases among animals and from animals to humans. Apart from this, the growing livestock industry, essential for the economy, requires enhanced disease management practices to sustain productivity and meet the high standards of animal product consumption. In addition to this, technological advancements in vaccine research and development have led to more effective and longer-lasting vaccines, encouraging their widespread use.
However, Mexico Animal Vaccines Market faces few restraints such as the high cost associated with the development and distribution of animal vaccines. This cost factor can be a barrier for widespread adoption, especially in rural areas with limited financial resources. Apart from this, the lack of infrastructure for the proper storage and transportation of vaccines poses a significant challenge, as vaccines often require specific temperature conditions to remain effective. In addition to this, regulatory challenges and the lengthy approval process for new vaccines can delay their introduction to the market. This slow pace fails to keep up with the emergence of new pathogens and diseases, potentially putting animal populations at risk.
The Mexico animal vaccines industry is dominated by a few key players who are well-established within the industry. These leading companies include Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH, and Elanco Animal Health Incorporated. Zoetis Inc. is renowned for its extensive product portfolio and innovative approaches to animal health. Merck & Co., Inc. leverages advanced research and development to offer a wide range of vaccines catering to different species. Boehringer Ingelheim GmbH emphasizes on strategic mergers and acquisitions to expand its market share. Lastly, Elanco Animal Health Incorporated focuses on integrating comprehensive animal vaccine solutions to enhance disease prevention and control.
The animal vaccines market in Mexico is governed by a framework of stringent regulations designed to ensure the safety, efficacy, and quality of veterinary medicines. The Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) is the principal regulatory body overseeing the approval and monitoring of animal vaccines. COFEPRIS mandates rigorous testing protocols and clinical trials for new vaccines to prevent the introduction of harmful products to the market. Additionally, manufacturers must adhere to Good Manufacturing Practices (GMP) to ensure consistency and reliability in vaccine production. These regulations are essential for safeguarding animal health, which in turn, influences public health and the economy by preventing zoonotic diseases and ensuring the productivity of livestock.
The future of Mexico Animal Vaccines Market looks promising due to various factors such as the ongoing development of more effective vaccination strategies. Innovations in vaccine technology, such as mRNA vaccines, which have gained prominence in human health, are expected to find their way into veterinary medicine. In addition to this, increasing collaboration between government bodies, private sector entities, and international organizations will amplify efforts to improve animal health standards. Public-private partnerships are expected to flourish, driving innovation, and facilitating the reach of vaccination programs to even the most remote areas.
According to Shubham, Senior Research Analyst, 6Wresearch, Recombinant Vaccines are projected to grow at robust pace due to the ability of recombinant vaccines to offer high levels of safety and efficacy positions them as a preferred choice for animal health professionals.
Companion animal vaccine market is expected to dominate the Mexico Animal Vaccines Market Share in the coming years due to the increasing pet ownership rates in Mexico reflect a broader global trend towards humanizing pets, leading to pet owners investing more in their animals' health and well-being, including regular vaccinations.
Intranasal vaccine market is projected to grow substantially in the future years due to the growing preference for intranasal vaccines is largely attributed to their ease of administration and the reduced stress they impose on animals, particularly companion animals like dogs and cats.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Animal Vaccines Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Animal Vaccines Market Revenues & Volume, 2020 & 2030F |
3.3 Mexico Animal Vaccines Market - Industry Life Cycle |
3.4 Mexico Animal Vaccines Market - Porter's Five Forces |
3.5 Mexico Animal Vaccines Market Revenues & Volume Share, By Product, 2020 & 2030F |
3.6 Mexico Animal Vaccines Market Revenues & Volume Share, By Animal Type, 2020 & 2030F |
3.7 Mexico Animal Vaccines Market Revenues & Volume Share, By Route of Administration, 2020 & 2030F |
4 Mexico Animal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mexico Animal Vaccines Market Trends |
6 Mexico Animal Vaccines Market, By Types |
6.1 Mexico Animal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Mexico Animal Vaccines Market Revenues & Volume, By Product, 2020 - 2030F |
6.1.3 Mexico Animal Vaccines Market Revenues & Volume, By Attenuated Live Vaccines, 2020 - 2030F |
6.1.4 Mexico Animal Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2020 - 2030F |
6.1.5 Mexico Animal Vaccines Market Revenues & Volume, By Subunit Vaccines, 2020 - 2030F |
6.1.6 Mexico Animal Vaccines Market Revenues & Volume, By DNA Vaccines, 2020 - 2030F |
6.1.7 Mexico Animal Vaccines Market Revenues & Volume, By Recombinant Vaccines, 2020 - 2030F |
6.2 Mexico Animal Vaccines Market, By Animal Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Animal Vaccines Market Revenues & Volume, By Livestock, 2020 - 2030F |
6.2.3 Mexico Animal Vaccines Market Revenues & Volume, By Companion, 2020 - 2030F |
6.3 Mexico Animal Vaccines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Animal Vaccines Market Revenues & Volume, By Subcutaneous, 2020 - 2030F |
6.3.3 Mexico Animal Vaccines Market Revenues & Volume, By Intramuscular, 2020 - 2030F |
6.3.4 Mexico Animal Vaccines Market Revenues & Volume, By Intranasal, 2020 - 2030F |
7 Mexico Animal Vaccines Market Import-Export Trade Statistics |
7.1 Mexico Animal Vaccines Market Export to Major Countries |
7.2 Mexico Animal Vaccines Market Imports from Major Countries |
8 Mexico Animal Vaccines Market Key Performance Indicators |
9 Mexico Animal Vaccines Market - Opportunity Assessment |
9.1 Mexico Animal Vaccines Market Opportunity Assessment, By Product, 2020 & 2030F |
9.2 Mexico Animal Vaccines Market Opportunity Assessment, By Animal Type, 2020 & 2030F |
9.3 Mexico Animal Vaccines Market Opportunity Assessment, By Route of Administration, 2020 & 2030F |
10 Mexico Animal Vaccines Market - Competitive Landscape |
10.1 Mexico Animal Vaccines Market Revenue Share, By Companies, 2023 |
10.2 Mexico Animal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |